Genetic counseling for the public?

Community Genetics

Volumn 9, Issue 1, 2006, Pages 62-66

  Kunstmann, Erdmute ^a   Epplen, Jörg T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Decision making; Diagnostic tools; Genetic testing; Public health

Indexed keywords

CHROMOSOME DISORDER; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; DECISION MAKING; DEMENTIA; GASTROINTESTINAL DISEASE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; HUNTINGTON CHOREA; LEUKEMIA; MEDICAL PRACTICE; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROLOGIC DISEASE; PRENATAL SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; RISK FACTOR;

ARYL HYDROCARBON HYDROXYLASES; DECISION MAKING; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; PRENATAL DIAGNOSIS; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 33344469557     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090695     Document Type: Conference Paper

References (11)

1. Shetty HG, Woods F, Routledge PA: The pharmacology of oral anticoagulants: implications for therapy. J Heart Valve Dis 1993;2:53-62.
2. Kaminsky LS, Zhang ZY: Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67-74.
3. Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002;287:1690-1698.
4. Tauber AI: Sick autonomy. Perspect Biol Med 2003;46:484-495.
5. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, et al: A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-238.
6. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-983.
7. Meiser B, Dunn S: Psychological effect of genetic testing for Huntington's disease: an update of the literature. West J Med 2001;174:336-340.
8. D'Alton ME, DeCherney AH: Prenatal diagnosis. N Engl J Med 1993;328:114-120.
9. Hagard S, Carter FA: Preventing the birth of infants with Down's syndrome: a cost-benefit analysis. Br Med J 1976;i:753-756.
10. Harris RA, Washington AE, Nease RF Jr, Kuppermann M: Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 2004;363:276-282.
11. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L: First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-1413.